Top Markets
#1 Palladium Network Palladium Network +19.88%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.80%
#3 OpenEden OpenEden +13.40%
#4 MarsCoin MarsCoin +12.48%
#5 clBTC clBTC +12.08%
#6 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.74%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +8.57%
#8 Mantle Staked Ether Mantle Staked Ether +8.34%
#9 Mantle Restaked ETH Mantle Restaked ETH +8.01%
#10 Kinesis Silver Kinesis Silver +6.47%
Coin of the day
Palladium Network Palladium Network
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
ObsEva S.A. ObsEva S.A.

ObsEva S.A.

OBSN
Rankning i aktier #40302
ObsEva S.A. is a biopharmaceutical company focused on developing and... ObsEva S.A. is a biopharmaceutical company focused on developing and commercializing groundbreaking therapies for women facing challenges in reproductive health and pregnancy. Its product pipeline includes Linzagolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist currently in Phase III clinical trials. Linzagolix is being evaluated for its efficacy in treating pain associated with endometriosis and heavy menstrual bleeding linked to uterine fibroids in pre-menopausal women. The firm is also progressing with Ebopiprant, an oral and selective prostaglandin F2a (PGF2a) receptor antagonist, which is in Phase II clinical trials as a once-daily treatment for preterm labor occurring between 24 and 34 weeks of gestational age. Additionally, ObsEva is developing Nolasiban, an oral oxytocin receptor antagonist in Phase I clinical trials, aimed at enhancing clinical pregnancy and live birth rates for women undergoing in vitro fertilization. ObsEva S.A. was founded in 2012 and maintains its headquarters in Geneva, Switzerland.
Aktiekurs
$0.00156067
Senast synkroniserad: 2024-05-03
Marknadsvärde
$182.87K
Förändring (1 dag)
-72.69%
Förändring (1 år)
0.00%
Land
CH
Handel ObsEva S.A. (OBSN)

Kategori

Healthcare
Aktiekurshistorik för ObsEva S.A. (OBSN)
Högsta slutkurs: $0.00 den 2024-05-01

Lägsta slutkurs: $16.22 den 2018-07-01
Aktiekurshistorik för ObsEva S.A. från 2018 till 2026
Årlig aktiekursutveckling
År Prestanda
2024 -92.05%
2023 -71.26%
2022 -92.71%
2021 1.17%
2020 -41.38%
2019 -73.99%
2018 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 9.07%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.09%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 14.81%
BE